140 related articles for article (PubMed ID: 22642284)
1. Cancer care value-learning from others.
Gamble RB
Am J Manag Care; 2012 May; 18(3 Spec No.):SP139. PubMed ID: 22642284
[No Abstract] [Full Text] [Related]
2. Value in Oncology: It Is in the Eyes of the Beholder.
Nabhan C; Phillips EG; Feinberg BA
J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
[No Abstract] [Full Text] [Related]
3. Seeking value as cancer drug costs soar.
Bender E
Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
[TBL] [Abstract][Full Text] [Related]
4. Key factors impacting the delivery and financing of oncology care in the United States.
Goldsmith PJ; Paivanas T
J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
[No Abstract] [Full Text] [Related]
5. Can cancer care lead the way toward a value-based future?
Macmillan K
Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
[No Abstract] [Full Text] [Related]
6. Perspectives on Cost and Value in Cancer Care.
Saltz LB
JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
[No Abstract] [Full Text] [Related]
7. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
8. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
Shah S; Reh G
Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
[No Abstract] [Full Text] [Related]
9. Improving outpatient oncology practice: several steps into a long journey.
Conti RM; Bach PB
J Oncol Pract; 2014 Nov; 10(6):355-6. PubMed ID: 25316027
[TBL] [Abstract][Full Text] [Related]
10. United healthcare, five oncology practices try bundled payments.
Goozner M
J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
[No Abstract] [Full Text] [Related]
11. Tackling Cost: A Prescription for Spending Wisely.
Tempero M
J Natl Compr Canc Netw; 2019 Jun; 17(6):633. PubMed ID: 31200360
[No Abstract] [Full Text] [Related]
12. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
Rappaport M
J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
[No Abstract] [Full Text] [Related]
13. The long battle over payment for oncology services in the office setting.
Bailes JS; Coleman TS
J Oncol Pract; 2014 Jan; 10(1):1-4. PubMed ID: 24443726
[No Abstract] [Full Text] [Related]
14. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
15. The shortage of essential chemotherapy drugs in the United States.
Gatesman ML; Smith TJ
N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
[No Abstract] [Full Text] [Related]
16. Managed care & medical oncology: the focus is on value.
Danielson E; Demartino J; Mullen JA
J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
[TBL] [Abstract][Full Text] [Related]
17. Bending the cost curve in cancer care.
Smith TJ; Hillner BE
N Engl J Med; 2011 May; 364(21):2060-5. PubMed ID: 21612477
[No Abstract] [Full Text] [Related]
18. The high cost of cancer drugs and what we can do about it.
Siddiqui M; Rajkumar SV
Mayo Clin Proc; 2012 Oct; 87(10):935-43. PubMed ID: 23036669
[No Abstract] [Full Text] [Related]
19. Managing oncology drug costs in a constrained environment.
Clark P
Clin Adv Hematol Oncol; 2019 Feb; 17(2):90-93. PubMed ID: 30845110
[No Abstract] [Full Text] [Related]
20. Bending the cost curve in cancer care.
Good M; Good CB
N Engl J Med; 2011 Aug; 365(7):674-5; author reply 675-6. PubMed ID: 21848478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
